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1  | BACKGROUND
Currently, 10%- 15% of the Norwegian intensive care patients are 
aged 80 years or older.1- 5 This proportion will increase significantly 
over the next 20 years, but it is unlikely that resources for intensive 
care will increase correspondingly, as the hospitals have limited eco-
nomic resources and limited access to specialized health personnel. 
Intensive care patients over 80 years of age have a reduced long- 
term prognosis with a 1- year survival of about 40%.6- 10 Thus, elderly 
patients are in danger of being less prioritized in future intensive 
care medicine. Recent examples of such prioritization were seen in 
overfilled ICUs in countries like China, Italy, and Spain during the 
outbreak of COVID- 19. Therefore, it is important to find patient 
groups among elderly people who could benefit from intensive care, 
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Background: Today, 10%- 15% of Norwegian intensive care patients are ≥80 years. 
This proportion will increase significantly over the next 20 years, but it is unlikely that 
resources for intensive care increase correspondingly. Thus, it is important to estab-
lish which patients among elderly people will benefit from intensive care. The main 
objective of the study was to investigate the relationships between geriatric scoring 
tools and 30- day mortality.
Methods: The study included 451 Norwegian patients ≥80 years who were included 
in two prospective European observation studies (VIP (very old intensive care pa-
tient)1 of VIP2). Both studies included clinical frailty scale (CFS) while VIP2 also ob-
tained the geriatric scores, comorbidity and polypharmacy score (CPS), Short Form 
of Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), and Katz 
Activity of Daily Living score (Katz ADL).
Results: Survival after 30 days was 59.9%. Risk factors for 30- day mortality were 
increasing Sequential Organ Failure Assessment (SOFA) score (odds ratio (OR) 1.30; 
confidence interval (CI) 95% 1.22- 1.39) and (CFS) > 3 (CFS 4: OR 1.96 (CI 95% 1.01- 
3.81); CFS 5- 9: OR 1.81 (CI) 95% 1.12- 2.93)). Data from VIP2 showed that CFS was 
the only independent predictor of 30- day mortality when these scores were tested 
in multivariate analyses separately together with age, SOFA, and gender (OR 1.21 
(95% CI 1.03- 1.41)).
Conclusions: Elderly intensive care patients had a 30- day survival rate of 59.9%. 
Factors strongly associated with 30- day mortality were increasing SOFA score and 
increasing frailty (CFS). Other geriatric scores had no significant association with sur-
vival in multivariate analyses.
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and conversely, if there are particular groups who have little or no 
benefit from such treatment. This is both an ethically and health- 
politically important issue.
Advanced age, comorbidity, and disease severity at ICU ad-
mission predict partially the risk of death, but traditional intensive 
care scoring tools are inaccurate when applied in elderly ICU pa-
tients.10,11 Hence, it is conceivable that other geriatric factors are 
more important for outcome than acute illness characteristics, and 
that geriatric scoring tools, therefore, may perform better than tra-
ditional intensive care scoring tools. That was the research question 
of two large European studies, VIP112 of VIP2.13 However, intensive 
care medicine is differently organized in European countries, lead-
ing to a different patient population among countries. Thus, results 
from international studies cannot directly be transferred to each na-
tional context. We, therefore, present the specific result from the 
Norwegian population.
Based on a Norwegian cohort of intensive care patients aged 
80 years or older at the time of ICU admission, we have studied the 
association among frailty, cognitive failure, comorbidity, the general 
health condition, and 30- day mortality.
2  | METHODS
2.1 | Design of study population
Data presented in this paper are based on two prospective obser-
vational studies (VIP112 and VIP213 ), which included intensive care 
patients ≥80 years in Europe. Norwegian participants from these 
studies were merged into one study population. Outcome in the 
studies was ICU survival and survival 30 days after ICU admission.
In total, 18 Norwegian ICUs participated in the VIP studies, 
where 12 were local hospitals and 6 were university hospitals (VIP1: 
14 ICUs (4 university hospitals and 10 local hospitals); VIP2: 14 ICUs 
(5 university hospitals and 9 local hospitals)).
Inclusion criteria in both studies were acute ICU admissions of 
patients ≥80 years of age. VIP1 included also elective ICU admis-
sions, but since this is not common practice in Norway, we consid-
ered the inclusion criteria as similar in both studies. In VIP1, each 
participating ICU could choose to either include all patients within a 
time period of 3 months (October 2016– February 2017), or the first 
20 patients within the same time period. In VIP2, each participating 
ICU could choose to either include all patients within a 6- month pe-
riod (May 2018– February 2019) or the first consecutive 20 patients 
during the same time period. The 30- day mortality follow- up was on 
July 15th, 2019. Information on ICU admission triage decisions was 
not collected in either of the studies.
VIP1 and VIP2 were coordinated by the Health Services Resource 
and Outcome (HSRO) section of the European Society of Intensive 
Care Medicine (ESICM). National coordinators were responsible for 
recruitment of ICUs. Information about the studies was published 
on a dedicated website (www.vipst udy.org). Patient data entry was 
enabled through an electronic case report form (eCRF), with data 
storage on a server in Århus, Denmark. Both studies were registered 
in ClinicalTrial.gov (NCT03134807 (VIP1); NCT0337069 (VIP2)).
2.2 | Data collection
For all patients in both studies, we collected demographic data 
(age, sex, and place of living before hospital admission), ICU length 
of stay (ICU- LOS), ICU treatment (vasoactive medication, mechani-
cal ventilation (invasive and non- invasive), and renal replacement 
treatment (RRT)), and life- sustaining treatment (LST) limitation 
(withhold/withdrawal) during the ICU stay. The frailty status be-
fore the actual critical illness was scored with clinical frailty scale 
(CFS)14 by either a physician or a nurse. Sources for CFS scoring 
were patients, proxies, or patient records. The following defini-
tions for CFS were used: not frail = CFS 1- 3, vulnerable = CFS 4, 
and frail = CFS ≥ 5. SOFA (Sequential Organ Failure Assessment) 
score was used for assessment of severity of illness.15 The primary 
reason for ICU admission was grouped according to a list consisting 
of the following 11 categories: respiratory failure, circulatory fail-
ure, combined respiratory/circulatory failure, sepsis (severe sepsis 
in VIP1 and sepsis in VIP2), multitrauma without head injury, multi-
trauma with head injury, isolated head injury, postemergency sur-
gery, intoxication, non- traumatic cerebral failure, and other causes 
(Table 1).
In VIP2, there was also collected information on place of living 
before hospital admission, duration of ICU treatment, and geriatric 
syndromes. For collection of data regarding the geriatric syndromes, 
the following scores were used: comorbidity and polypharmacy 
score (CPS16 ; comorbidity), Short form of Informant Questionnaire 
on Cognitive Decline in the Elderly (IQCODE17 ; cognitive function), 
and Katz Activity of Daily Living score (Katz ADL18 ; daily activity). 
IQCODE was scored by proxies, while Katz ADL also could be scored 
based on information from the patient. High degree of comorbidity 
was defined as CPS ≥15.19 Cognitive decline was defined as IQCODE 
>3.5, which corresponds to a Mini Mental State evaluation of ≥22.20 
Disability was defined as Katz ADL ≤4, corresponding to a patient 
Editorial Comment
Traditional intensive care scoring tools are inaccurate 
when applied in elderly intensive care patients. Recently, 
interest in frailty has increased in intensive care medicine 
through the scoring tool “Clinical Frailty Scale” (CFS), es-
pecially regarding intensive care for elderly patients. This 
study showed that cognitive deficit and functional decline, 
in addition to frailty, were strongly associated with 30- day 
mortality among intensive care patients aged 80 years and 
above. On the other hand, comorbidity and polypharmacy, 
measured with comorbidity and polypharmacy score (CPS), 
showed no strong association with survival.
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dependency in at least one of the following domains: bathing, dress-
ing, toileting, transferring, continence, and feeding.
Information about life- sustaining treatment (LST) limitation 
(withholding/withdrawal) was collected during the ICU stay, and 
the time (days) until LST limitation decision was counted from ICU 
admission.
2.3 | Statistics
Patient characteristics were analyzed as percentages for categorical 
variables, while continuous variables were measured as means with 
standard deviation if the distribution was symmetrical, and medians 
with quartiles if the distribution was skewed. The main analysis was 
performed with logistic regression with 30- day mortality as outcome 
variable, and age, sex, severity score (SOFA), and frailty (CFS) as ex-
posure variables. Information about geriatric scores (CPS, IQCODE, or 
Katz ADL) was not available in VIP1. Thus, we performed five different 
regression analyses with data from VIP2 (N = 238) to compare these 
geriatric scores with CFS. Missing observations was handled with the 
use of R- package mice for the generation and analysis of 100 impu-
tated data set. Principal component analysis (PCA) was used for age, 
SOFA score, CFS, Katz ADL, CPS, and IQCODE. PCA is a technique 
that can be used to visualize the association between variables in a 
data set with many variables. In a data set with only two variables, one 
may plot them against each other, but because we have six variables, 
we would need a six dimensional plot. However, with PCA we may still 
plot these variables using only two axes, but the cost is that some nu-
ances are lost. This cost can be described as “explained variance.” The 
six- dimensional plot mentioned earlier would have 100% explained 
variance. Missing information in the PCA analyses was imputed by 
using the R- packages FactoMineR and missMDA to regularized itera-
tive PCA.
2.4 | Ethics
Both VIP1 and VIP2 included patients who usually lacked the ability 
to give an informed consent, and the ethical committees waived the 
need for consent at inclusion. Survivors later received information 
about the studies and were given the possibility to decline partici-
pation in the studies. Both studies were approved by the Regional 
Committee of Medical and Health Research Ethics in Central Norway 
(VIP1: REC West 2016/806; VIP2: REC South- East 2018/87).
3  | RESULTS
In total, 451 patients from Norway were included in VIP1 and VIP2 
(VIP1: N = 215; VIP2: N = 236). Median age was 85 years, and 51.9% 
were women. Respiration and/or circulatory failure and sepsis were 
the main reasons for ICU admission in 67.1% of the cases. The per-
centage of patients admitted to university hospitals was 28.6%. The 
majority of patients lived in their own homes before hospital admis-
sion (81.3%; of whom 9.7% lived with their family) (Table 2).
Invasive mechanical ventilation was given to 30.4% of the pa-
tients, while 36.6% received non- invasive mechanical ventila-
tion. Median length of stay in the ICU (ICU- LOS) was 48.0 hours 
(2.0 days). Vasoactive medication was given to 61.9% of the patients, 
while 5.3% received renal replacement treatment. Mean SOFA score 
was 6,8.
More than half of the patients were counted as frail (CFS ≥5; 
51.9%), while 33.9% were counted as non- frail (CFS 1- 3) and 14.2% 
as vulnerable (CFS 4). Median CFS was 5.0. Regarding the other 
geriatric scores, 22.9% had a high degree of comorbidity (CPS >15), 
35.1% had a cognitive failure (IQCODE value >3.5), and 24.4% had a 
disability (Katz <4).
In total, 60.3% of the patients received LST limitation decisions 
during the ICU stay. Of patients who died within 30 days, treatment 
was withheld in 66.9% and withdrawn in 44.2%. Median time to de-
cision of withhold was 1 day and withdrawal 2 days.
ICU survival was 82.0%, while 30- day survival was 59.9%. 
Among patients who died within 30 days after ICU admission, 55.2% 
survived the ICU stay. Predictors of 30- day mortality were higher 
SOFA score (OR 1.30; CI 95% 1.22- 1.39) and CFS >3 (CFS 4: OR 1.96 
(CI 95% 1.01- 3.81); CFS 5- 9: OR 1.81 (CI 95% 1.12- 2.93)) (Table 3). 
We found no significant differences between patients with a CFS 
of 4 and CFS 5- 9. Among patients in the group CFS 5- 9, 152 of 234 
patients had values 5 or 6.
Table 4, containing data from VIP2, shows that IQCODE was the 
geriatric score that was most strongly associated with the 30- day 
mortality. However, CFS was the single independent predictor for 
30- day mortality when the geriatric scores were tested in separate 





Length of stay (ICU and after 30 d) X
Reason for ICU admission (11 
categories)
X Except elective 
surgery
Severity of illness (SOFA) X
Frailty (Clinical Frailty Scale) X
Place of living before hospital 
admission
X
ICU treatment: mechanical ventilation, 
vasoactive medication, tracheostomy, 
and renal replacement therapy
X
Hours of ICU treatment X
Life- sustaining treatment limitation 
(withhold/withdrawal)
X
Scores of comorbidity, cognitive 
failure, and daily activities
X
Survival (ICU and after 30 d) X
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TA B L E  2   Status of patient characteristics 30 d after admission to the ICU
Data variables Number All Dead Survivors P- value
Patients — 451 181 270 — 
Age, median (IQR) 451 85 (6) 85 (6) 85 (6) .31d 
Female, n (%) 451 234 (51.9) 83 (45.9) 151 (55.9) .05b 
Living status before hospital admission, n (%)e  236
Home 169 (71.6) 71 (73.2) 98 (70.5) .76b 
Home with family 23 (9.7) 5 (5.2) 18 (12.9) .08b 
Nursing home 34 (14.4) 17 (17.5) 17 (12.2) .34b 
Other ward at the hospital 7 (3.0) 4 (4.1) 3 (2.2) .45c 
Other 3 (1.3) 0 (0.0) 3 (2.2) .27c 
Reason for admission, n (%) 451
Respiratory failure 101 (22.4) 42 (23.2) 59 (21.9) .82b 
Circulatory failure 97 (21.5) 42 (23.2) 55 (20.4) .55b 
Combined respiratory and circulatory failure 0 (9.5) 22 (12.2) 21 (7.8) 0.17b 
Sepsis 62 (13.7) 25 (13.8) 37 (13.7) 1.00b 
Multitrauma without head injury 16 (3.5) 5 (2.8) 11 (4.1) .61c 
Multitrauma with head injury 9 (2.0) 7 (3.9) 2 (0.7) .03c 
Isolated head injury 8 (1.8) 3 (1.7) 5 (1.9) 1.00c 
Non- traumatic cerebral failure 14 (3.1) 6 (3.3) 8 (3.0) 1.00b 
Postemergency surgery 59 (13.1) 21 (11.6) 38 (14.1) .53b 
Other reason 42 (9.3) 8 (4.4) 34 (12.6) .01b 
University hospital, n (%) 451 129 (28.6) 67 (37.0) 62 (23.0) .002b 
Invasive ventilation
n (%) 451 137 (30.4) 80 (44.2) 57 (21.1) <.001b 
Time (h), mean (SD)e  70 76.2 (88.6) 57.1 (63.7) 103.3 (110.7) .05a 
Non- invasive ventilation (NIV)
n (%) 451 165 (36.6) 80 (44.2) 85 (31.5) .01b 
Time (h), mean (SD)e  87 18.5 (21.8) 14.8 (16.9) 21.5 (24.9) .14a 
Tracheostomy, n (%)e  236 5 (2.1) 0 (0.0) 5 (3.6) .08c 
Vasoactive medication
n (%) 451 279 (61.9) 127 (70.2) 152 (56.3) .004b 
Time (h), mean (SD)e  160 53.4 (69.0) 51.0 (61.5) 55.4 (74.8) 0.68a 
Renal replacement therapy
n (%) 451 24 (5.3) 14 (7.7) 10 (3.7) 0.10b 
Time (h), mean (SD)e  14 88.2 (96.8) 74.8 (74.9) 112.4 (134.6) 0.59a 
SOFA score, mean (SD) 451 6.8 (3.5) 8.5 (3.5) 5.7 (3.1) <0.001a 
CFS, median (IQR) 451 5.0 (3.0) 5.0 (3.0) 4.0 (3.0) 0.04d 
CFS 1- 3 (not frail), n (%) 153 (33.9) 51 (28.2) 102 (37.8) 0.04b 
CFS 4 (vulnerable), n (%) 64 (14.2) 29 (16.0) 35 (13.0) 0.44b 
CFS 5- 9 (frail), n (%) 234 (51.9) 101 (55.8) 133 (49.3) 0.21b 
Geriatric scoring tools
CPS, median (IQR)e  236 12.0 (7.0) 12.0 (7.0) 11.0 (6.5) 0.91d 
High degree of comorbidity (CPS >15), n (%) 54 (22.9) 22 (22.7) 32 (23.0) 1.00b 
IQCODE, median (IQR)e  171 3.3 (1.0) 3.4 (1.0) 3.2 (0.6) 0.08d 
Cognitive failure (IQCODE >3,5), n (%) 60 (35.1) 28 (40.6) 32 (31.4) 0.28b 
Katz, median (IQR)e  213 5.0 (3.0) 5.0 (3.0) 6.0 (2.0) 0.06d 
Functional disability (Katz <4), n (%) 52 (24.4) 24 (28.2) 28 (21.9) 0.37b 
(Continues)
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multivariate analyses with age, SOFA, and sex (OR 1.21 (95% CI 1.03- 
1.41)). When all the scores were included in a multiple regression 
analysis, we found no significant impact in the model. Figure 1 shows 
the different variables in the PCA relative to the first two princi-
pal components. These two components contribute with a total 
of 40.53% + 17.64% = 58.17% explained variance. As mentioned, 
including six dimensions would yield 100% explained variance. In 
other words, the first two principal components can be said to ap-
proximate the full data set very well. The angles between the arrows 
show the degree of correlation between the variables (0° means 
100% positive correlation, 90° means no correlation, while 180° 
means 100% negative correlation). The length of the arrows shows 
how much weight each variable has on each principal component. 
Katz ADL and IQCODE have more points because these variables 
lacked several observations that had to be imputed. Because 
IQCODE was scored by proxies, and Katz ADL was scored by prox-
ies or patients, we believe that the missingness was random in the 
sense that the score itself was not the reason for the missingness. 
As seen, CFS and the other geriatric scores are correlated with each 
other, while CFS has the longest arrow, and this finding corresponds 
well with the regression analyses.
4  | DISCUSSION
In this Norwegian cohort of ICU patients ≥80 years, we found that 
82.0% survived the ICU stay and that 30- day survival was 59.9%. 
Factors strongly associated with 30- day mortality were higher SOFA 
score and higher frailty (CFS). Other geriatric scores for comorbid-
ity, daily activity, and cognitive function had no significant associa-
tion with survival in multivariate analyses. In our Norwegian cohort, 
we found more LST limitation decisions compared with the total 
European cohort in the VIP studies.
A survival rate after 30 days of around 60% correlates well 
with the total results from the rest of Europa (VIP1 62.0%21 ; VIP2 
61.1%13). When comparing our results with other Norwegian co-
horts regarding ICU patients ≥80 years, we found similar results with 
a hospital survival of just below 60%.6,8,22 Survival for elderly pa-
tients is, therefore, as expected, lower than for younger patients,22 
but nevertheless we should consider offering ICU treatment for el-
derly as a group. Initiating ICU treatment should, therefore, be based 
Data variables Number All Dead Survivors P- value
LST limitation
Withhold of therapy
n (%) 451 189 (41.9) 121 (66.9) 68 (25.2) <0.001b 
Days from ICU admission to withhold, median 
(IQR)
117 1.0 (1.0) 1.0 (1.0) 1.0 (1.0) 0.52d 
Withdrawal of therapy
n (%) 451 83 (18.4) 80 (44.2) 3 (1.1) <0.001b 
Days from ICU admission to withdrawal, median 
(IQR)
44 2.0 (3.0) 2.0 (3.0) 1.5 (0.6) 0.48d 
Hours in the ICU, mean (SD) 451 88.8 (97.3) 75.8 (97.3) 97.4 (183.6) 0.10a 
Survival, n (%)
ICU 451 370 (82.0) 100 (55.2) 100 — 
30 d 451 270 (59.9) 0 (0.0) 100 — 
Abbreviations: CFS, Clinical frailty scale; CI, confidence interval; CPS, Comorbidity and polypharmacy score; ICU, intensive care unit; IQCODE, Short 
form of Informant Questionnaire on Cognitive Decline in the Elderly; IQR, interquartile range: Katz ADL, Katz activity of daily living score; LST, life- 




dWilcoxon rank- sum test,
eOnly in VIP2 cohort.
TA B L E  2   (Continued)
TA B L E  3   Risk of death 30 d after ICU admission
OR (95% CI) P- value
Age 1.03 (0.98- 1.09) .2
Sex 0.80 (0.53- 1.22) .3
SOFA 1.30 (1.22- 1.39) <.001
CFS
1- 3 1 (ref.) — 
4 1.96 (1.01- 3.81) .046
5- 9 1.81 (1.12- 2.93) .016
Abbreviations: CFS, Clinical frailty scale; CI, confidence interval; OR, 
Odds ratio; ref., reference category; SOFA, Sequential organ failure 
assessment.
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on an individual basis for patients aged 80 years or older, preferably 
on the basis of established risk factors for poor outcome.
The term “frailty” has been established in geriatrics decades ago, 
and is evaluated in two different ways; a phenotypical model23 and 
a cumulative deficit model.24,25 Recently, interest in frailty has in-
creased in intensive care medicine through the simple scoring tool 
“Clinical frailty scale” (CFS), especially regarding intensive care for 
elderly patients. One reason for the emergence of the CFS might 
be due to its visual simplicity. The scoring tool has also correlated 
well with clinically important outcomes in large studies.26,27 In our 
study, we found that the majority of the patients were categorized 
as frail. Increasing frailty showed to be a strong prognostic factor for 
30- day mortality, which again corresponded to the main conclusions 
from both VIP studies. A Canadian study has also found that frailty 
correlates with health- related quality of life.28
Since frailty showed strong correlation with survival in VIP1, 
other geriatric variables were tested in VIP2. Findings from our 
study were that cognitive deficit and functional decline, in addition 
to frailty, were strongly associated with 30- day mortality, but that 
CFS was a better predictor than the other scores. However, regis-
tration of cognitive deficit and functional decline did not provide 
additional prognostic value when CSF was used. All of these fac-
tors performed better than age alone. Comorbidity and polyphar-



























































































































































































































































































































































































































































































































































































































F I G U R E  1   Principal component analysis was performed for 
age, SOFA score, CPS, Katz ADL, CFS, IQCODE and CPS. The 
first principal component (Dim 1) explains 40.53% of the variation 
between the variables, while the second principal component (Dim 
2) explains 17.64%. Together, these two components contribute 
with a total of 58.17% explained variance. The angles between the 
arrows show correlation between the variables (90 degrees for 
0 correlation, 0 degrees for perfect positive correlation, and 180 
degrees for perfect negative correlation). The length of the arrows 
shows how much weight a variable has on each component. For 
Katz ADL and IQCODE, information on some of the patients was 
missing. The point clouds illustrate the uncertainty this has caused 
for the estimate of the arrows
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survival.13 It is important to recognize that this applies to 30- day 
mortality. Decisions on not to start ICU treatment are not based on 
short- term survival alone. Cognitive impairment, disability, and other 
comorbidities can be good reasons to expect such a poor functional 
outcome that it is not appropriate to expose the patient to advanced 
medical treatment.
There are large variations in the degree of LST limitations in 
Europe.29,30 Of patients who died within 30 days in the VIP1 and 
VIP2 studies, 24.3% and 49.2%, respectively, had decisions to with-
hold LST, while in 34.6% and 34.4% of cases, respectively, LST was 
withdrawn.21 In our Norwegian study, we have somewhat higher 
figures, with 66.9% (withholding) and 44.2% (withdrawal). A sub- 
study from VIP1 supports our findings.31 It showed that in countries 
with a high gross domestic product (GDP) there was a higher degree 
of LST limitation, while it was lower in countries where religion is 
high. It was also found that patients admitted to ICUs in the north-
ern part of Europe, and especially in the Nordic countries, had a 
higher proportion of LST limitation. Hence, Norwegian ICUs have 
a greater degree of LST limitation of intensive care patients aged 
80 years or older compared with the rest of Europe. Intuitively, one 
would think that this could be related to a relatively low intensive 
care capacity in Scandinavia compared to many other countries in 
Europe, defined as the number of intensive beds per 100 000 in-
habitants, where Norway in 2014 had 8.0 and Germany had 29.2 
(most intensive beds per capita in Europe).32 However, despite that 
difference in ICU capacity, that factor was not crucial to the degree 
of LST limitations.31
There are currently no clinical guidelines on how to choose which 
of the oldest patients will be offered intensive care, a so- called “tri-
age”. Traditional severity scores are not intended for individual use 
in triage, and are validated for a general intensive population, not for 
the elderly people. Based on data from VIP1, an attempt was made 
to create a model for predicting death within 30 days after admis-
sion to the intensive care unit.33 Even after including many variables 
in the model, it was not possible to accurately predict who will die 
within 30 days. In anticipation of better models, many will rely on 
a so- called “Time Limited Trial” where elderly, critically ill patients 
are admitted to the ICU, and then are given advanced medical treat-
ment for a few days to see if they respond to the measures during 
this "trial period”.6,34 At the same time, more information is gathered 
about comorbidity, cognitive function, frailty, and level of function, 
as well as whether the treatment is in line with the patient's and rela-
tives' suitable view of advanced intensive care. Treatment limitation, 
either not stepping up or ending treatment, will be a decision made 
by the treatment team. Based on our study and the other VIP stud-
ies, as well as several other studies, using the "Clinical frailty scale", 
as part of the assessment of further treatment level, will be very 
useful in such contexts.
This study has several strengths. Prospective data have been 
obtained from both local and university hospitals in Norway, where 
all parts of the country were represented. Information was also ob-
tained from relatives regarding cognitive function and functional 
status. There are also some limitations. Firstly, we cannot rule out 
a certain form of selection bias, as we have no information about 
those patients who were not admitted to ICUs. The patients’ care-
givers may think that the patient in any case will not be accepted 
for intensive care treatment due to a full ICU capacity and, there-
fore, probably will not be prioritized, a so- called "hidden triage.” 
Also, no information was obtained about the selection process of 
which patients were accepted for intensive care by an ICU physi-
cian, and which were rejected. Such a process is often referred to as 
the "ICU triage.” Furthermore, we cannot rule out information bias 
regarding misclassifications of the scores. However, a recent sub- 
study of the VIP2 study showed a high reliability in the scoring of 
CFS.35 Secondly, we have no data on decisions on treatment limita-
tion after the intensive care unit. Thirdly, there will be a difference in 
patient populations between hospitals that have intermediate units 
and those hospitals that have intermediate patients and postoper-
ative monitoring patients also admitted to the intensive care unit. 
Fourthly, we used a composite score for comorbidity, which do not 
identify specific chronic diseases as risk factors.
5  | CONCLUSION
In this study of intensive care patients aged 80 years or older, we 
found a 30- day survival rate after ICU admission of 59.9%. Factors 
strongly associated with 30- day mortality were increasing severity 
scores (SOFA) and increasing frailty (CFS). Other geriatric scores for 
comorbidity, daily activities, and cognitive function were not signifi-
cantly associated with survival in multivariate analyses. Using the 
clinical frailty scale as a measure of frailty can be an important tool 
for treatment decisions.
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